Comparison between effects of Teicoplanin versus Vancomycin in treatment of catheter infection in hemodialysis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138903234144N2

Enrollment

Registered

2010-06-13

Start date

2009-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patients who had catheter infection. Other infectious diseases

Interventions

Intervention 1: Teicoplanin: 800mg intra venues as loading dose and 400mg at 2th,3th,5th,12th,19th days. Intervention 2: Vancomycin: 1gr intra venues as loading dose and 500mg each 5 days for 3 weeks.

Treatment - Drugs

Teicoplanin: 800mg intra venues as loading dose and 400mg at 2th,3th,5th,12th,19th days

Vancomycin: 1gr intra venues as loading dose and 500mg each 5 days for 3 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with clinical suspicious of catheter infection after roll out of other causes of fever. Exclusion criteria: patients who had purulent discharge from catheter site at the beginning of study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Absence of fever after 72 hours. Timepoint: 24 hours. Method of measurement: thermometer.	—

Secondary

Measure	Time frame
Drug adverse effect. Timepoint: 24 hours. Method of measurement: patient's complain and physical exam.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Maliheh Yarmohamadi

Semnan university of medical sciences

mds@sem-ums.ac.ir+98 23 1444 3912

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026